TickerFactsScreenerDevelopers

Krystal Biotech, Inc. (KRYS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: $289.0K2017: $49.47M2018: $113.23M2019: $202.91M2020: $292.08M2021: $593.58M2022: $522.23M2023: $778.64M2024: $946.38M2025: $1.22B$1.22B
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$1.22B+28.9%
2024$946.38M+21.5%
2023$778.64M+49.1%
2022$522.23M-12.0%
2021$593.58M+103.2%
2020$292.08M+43.9%
2019$202.91M+79.2%
2018$113.23M+128.9%
2017$49.47M+17019.0%
2016$289.0K—